Author

Ali Darwich

Heidelberg UniversityORCID 0000-0001-9463-9638Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alessa Klär· 1 shared Alexander StreueriD· 1 shared Ann‐Christin Belzer· 1 shared Daniel NowakiD· 1 shared Eva AltrockiD· 1 shared Felicitas RappiD· 1 shared Franziska Hofmann· 1 shared Georgia Metzgeroth· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessa Klär

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 22, 2025

Primary CD34+ cells of patients with VEXAS syndrome are highly sensitive to targeted treatment with TAK-243 and pevonedistat

Daniel Nowak, Marie Demmerle, Alessa Klär…·Nanni Schmitt

This study shows that VEXAS patient-derived CD34+ cells are more sensitive to TAK-243 and pevonedistat than MDS and healthy controls, suggesting potential targeted therapy.

DOI 10.1101/2025.05.22.653244

humanexperimental assay

𝕏 PostBluesky